ClinicalXchange Internal Medicine podcasts

How common is treatment inertia in the treatment of adult patients with T2D and what can be done about it? Join a multidisciplinary panel including Jim Gavin, MD, PhD; Steve Vacalis, DO; and Jodi Strong, DNP, CDE, BC-ADM, CPT as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia

Jodi Strong, DNP, CDCES, BC-ADM, CPT
Aspirus Medical Group
Stevens Point, Wisconsin

Steve Vacalis, DO
Senior Lead Physician
CaroMont Family Medicine, CaroMont Regional Medical Center 
Gastonia, North Carolina

What do you need to know about a once-daily GLP-1 RA and what can you do to help your patients taking this T2D therapy? Join this multidisciplinary discussion with Jim Gavin, MD; Curtis Triplitt, PharmD; and Jeffrey Unger, MD, as they review the mechanism of action, dosing, efficacy, and safety of a once-daily GLP-1 RA for adult patients with T2D.  

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia

Jeff Unger, MD, FAAFP, FACE
Diplomate, American Board of Family Practice
Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine
Riverside, California
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, California

Curtis L. Triplitt, PharmD, CDCES, FADCES
Clinical Associate Professor of Medicine Division of Diabetes
University of Texas Health at San Antonio
Texas Diabetes Institute, part of the University Health System
San Antonio, Texas

Faculty:

Neil Skolnik, MD
Family Physician & Professor of Family & Community Medicine
Sidney Kimmel Medical College,
Thomas Jefferson University

Corinne Young, FNP-C, FCCP
Nurse Practitioner
Pulmonary, Critical Care, and Sleep Medicine
Colorado Springs Pulmonary Consultants, PC

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia

Robert Busch, MD
Director of Clinical Research
Albany Med Faculty Practice, Community Endocrine Group
Albany, New York  

Pablo F. Mora, MD, FACE, MSc, CDCES
Endocrinologist, North Texas Diabetes & Endocrinology
Clinical Professor, Division of Endocrinology at University of Texas Southwestern Medical Center
Dallas, Texas

Rita F. Redberg MD, MSc, FACC
Professor of Medicine
Araxe Vilensky Endowed Chair in Cardiology
Faculty, Philip R Lee Institute for Health Policy Studies
Editor, JAMA Internal Medicine
Director, Inquiry Program
UCSF Division of Cardiology
San Francisco, CA

Nearly one-fourth of American adults take lipid-lowering statin medications. However, more people may be eligible. Statin Wars continue to be underway over whether statins should be used not just for the secondary prevention of cardiovascular disease (CVD), but also primary prevention. 

Event Sponsors
This event is sponsored by Clinical Care Solutions and is not sponsored by industry.

Presenter:

Michael J. Bloch MD, FACP, FASH, FNLA, FSVM
Associate Professor, University of Nevada School of Medicine
Medical Director, Renown Vascular Care, Renown Institute for Heart and Vascular Health
President, Blue Spruce Medical Consultants, PLLC
Reno, Nevada

Hypertension is commonly seen in primary care practice settings.  It requires up-to-date evidence-based management to optimize clinical outcomes for patients. This activity presents multiple clinical pearls on this topic through a Q&A format, highlighting common clinical challenges that primary care physicians face when treating patients with hypertension. Using recent data and existing guidelines, recommendations for management will be reviewed starting from diagnosis through initial treatment selection.

Follow along with the slideset located here: 
https://bit.ly/3AD5ln9

Presenter:

Javed Butler MD, MPH, MBA
Professor and Chairman
Department of Medicine
University of Mississippi
Jackson, Mississippi

Heart Failure is a serious health concern amongst older adults, afflicting over 6 million Americans, the majority of whom are 65 years of age or older. It is the leading cause of hospitalization, morbidity, and mortality in this population. It is more challenging to diagnose and manage HF in older patients due to multiple factors including multimorbidity, polypharmacy, cognitive impairment, and frailty. Furthermore, clinicians struggle to remain up-to-date on key clinical trial data and recent guidelines on developing individualized treatment plans for patients. To improve outcomes for patients with HF, clinicians must be adept at recognizing its common signs or symptoms, conducting a thorough diagnostic evaluation, and developing a treatment plan that addresses the multiple challenges and complexities that this patient population faces. Here, we cover these key principles in a short, case-based teaching module.

Follow along with the slideset located here:
https://bit.ly/3EGHtBx

Presenter:

Samuel Louie, MD
Professor
Director, UC Davis Asthma Network (UCAN)
Director, Reversible Obstructive Airway Disease (ROAD) Center
Sacramento, CA

In this brief program, expert faculty will discuss the application of new options to improve outcomes for those with moderate to severe asthma. First, the faculty will describe the features of uncontrolled asthma and asthma phenotypes. Next, case studies will be used to aid in identification of patients with severe asthma for whom use of add-on biologic therapy may be appropriate based on efficacy, safety, and disease- and patient-specific factors. Finally, the faculty will share approaches to shared decision-making with patients that result in written action plans and strategies for addressing adherence and multidisciplinary management of asthma and its comorbidities.

Follow along with the slideset located here:
https://bit.ly/3Av1OXR